@jour, you are still prisoner of the conception that elite is being sold for its current products and for its pipeline.
These are just the cherry on top of the cake.
These true value of elite is a 90k sqft facility approved by the fda and the dea. If elite was producing branded drugs there within 6 months of the purchase, and not generic drugs, the value for the buyers is much more than the intrinsic value of elite. It is about the potential loss of sale that plays out
I wish $5b was true, but yeah even if $500m a year in sales, over three years, that's only $1.5 b. With $200m in profits each year, the sp would be about $1.50/share with p/e of 10. So how does this play out
The question is if we know it can take up to 18 months to build a new facility and get all the approvals from the Dea and the fda, how much more is it worth for a branded drugs company the 90k sqft we are putting in the market with all the drugs and pipelines we have
Market Data 
Markets 
AI
